Jeff Elton is the CEO at Concerto Health AI, the healthcare group of Symphony AI. Concerto Health AI's mission is to improve patient outcomes by accelerating the discovery and development of new medicines; optimizing clinical trials; providing HEOR analytics and services; and being the definitive source of real world data products and AI Solutions.
Prior to Concerto Health AI, Jeff was managing director and global head, Predictive Health Intelligence at Accenture. He has over 20 years of experience as a global executive and consultant in the biopharmaceutical and healthcare sectors. Prior to Accenture, he was global COO and SVP Strategy for the Novartis Institutes of BioMedical Research overseeing R&D operations in the US, Europe and Asia.
Prior to Novartis Jeff was a senior partner at McKinsey in the Medical Products & Pharmaceuticals practice, focused on R&D. He was also founding CEO, board member and senior advisor to five early stage companies in personalized oncology management, oncology diagnostics, protein therapeutics, neurodegenerative diseases, diabetes and nanotherapeutics.
Jeff holds a Ph.D. in Business Economics and Marketing and an MBA in Finance and Statistics from the University of Chicago Booth School of Business.